NOVADIP Biosciences S.A.

📍 Mont-Saint-Guibert, Belgium🗓 Founded 2013👥 47 employees💰 Last funded Aug 2015
Novadip Biosciences is a clinical-stage biopharmaceutical company founded to design, develop, and bring to the market a new class of regenerative tissue products to accelerate healing of large bone defects and injuries in a single treatment. Novadip’s lead allogeneic product, NVD-X3, employs a matrix containing multiple bioactive factors that induce accelerated tissue healing. Designed as an “off-the-shelf” product, NVD-X3 can be shipped and stored at room temperature and offers superior intraoperative handling characteristics. Novadip is also developing NVD-003, an autologous therapy derived from ASCs as a potential single treatment to save limbs and restore mobility in patients with congenital pseudarthrosis of the tibia (CPT). CPT is a rare pediatric bone condition. Learn more about our technology platform and clinical development programs at www.novadip.com Phone number: +32/10 77 92 20 E-mail: info@novadip.com VAT: BE0535.575.602 Privacy policy: https://novadip.com/privacy-policy/
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2013
Founded
Investor geography1 country
Belgium
2
Frequently asked questions
Who invested in NOVADIP Biosciences S.A.?
NOVADIP Biosciences S.A. has 2 investors on record on gritt.io, including 2 early-stage backers.
When did NOVADIP Biosciences S.A. last raise funding?
The most recent investment in NOVADIP Biosciences S.A. recorded on gritt.io was in August 2015.
When was NOVADIP Biosciences S.A. founded?
NOVADIP Biosciences S.A. was founded in 2013.
What industry is NOVADIP Biosciences S.A. in?
NOVADIP Biosciences S.A. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NOVADIP Biosciences S.A. based?
NOVADIP Biosciences S.A. is headquartered in Mont-Saint-Guibert, Belgium.